Pamela Rendi-Wagner

Summary

Affiliation: University of Vienna
Country: Austria

Publications

  1. ncbi New vaccination strategies for low- and non-responders to hepatitis B vaccine
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, University of Vienna, Vienna, Austria
    Wien Klin Wochenschr 114:175-80. 2002
  2. ncbi Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience
    P Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, University of Vienna, Kinderspitalgasse 15, A 1095, Vienna, Austria
    Vaccine 19:2055-60. 2001
  3. ncbi Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, Medical University of Vienna, Kinderspitalgasse 15, A 1095 Vienna, Austria
    Vaccine 23:427-34. 2004
  4. ncbi Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    P Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, University Vienna, Kinderspitalgasse 15, A 1095, Austria
    Vaccine 22:2743-9. 2004
  5. ncbi Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, University of Vienna, Kinderspitalgasse 15, A 1095 Vienna, Austria
    Acta Trop 81:167-73. 2002
  6. ncbi Active hospital-based surveillance of rotavirus diarrhea in Austrian children, period 1997 to 2003
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology and Pathophysiology, Medical University Vienna, and St Anna Kinderspital, Austria
    Wien Klin Wochenschr 118:280-5. 2006
  7. ncbi Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Austria
    Vaccine 25:5097-101. 2007
  8. ncbi Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Centre for Physiology and Pathophysiology, Medical University Vienna, Kinderspitalgasse 15, A 1090 Vienna, Austria
    Vaccine 24:5960-5. 2006
  9. ncbi Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection
    Maria Paulke-Korinek
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, A 1090 Vienna, Austria
    Vaccine 27:7027-30. 2009
  10. ncbi Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees
    Erika Garner-Spitzer
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
    Vaccine 27:197-204. 2009

Detail Information

Publications24

  1. ncbi New vaccination strategies for low- and non-responders to hepatitis B vaccine
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, University of Vienna, Vienna, Austria
    Wien Klin Wochenschr 114:175-80. 2002
    ..Future approaches include DNA vaccination and expression of HbsAg determinants in live recombinant vectors...
  2. ncbi Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience
    P Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, University of Vienna, Kinderspitalgasse 15, A 1095, Vienna, Austria
    Vaccine 19:2055-60. 2001
    ..The significant difference in SPRs and GMTs to the 10 microg-dose vaccine, however, may influence future immunisation practices for the elderly...
  3. ncbi Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, Medical University of Vienna, Kinderspitalgasse 15, A 1095 Vienna, Austria
    Vaccine 23:427-34. 2004
    ....
  4. ncbi Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    P Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, University Vienna, Kinderspitalgasse 15, A 1095, Austria
    Vaccine 22:2743-9. 2004
    ..This study indicates that after multiple TBE (booster) immunizations protection surpasses the currently advised TBE booster interval of 3 years, thus supporting reconsideration of the recommendations for booster intervals...
  5. ncbi Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, University of Vienna, Kinderspitalgasse 15, A 1095 Vienna, Austria
    Acta Trop 81:167-73. 2002
    ....
  6. ncbi Active hospital-based surveillance of rotavirus diarrhea in Austrian children, period 1997 to 2003
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology and Pathophysiology, Medical University Vienna, and St Anna Kinderspital, Austria
    Wien Klin Wochenschr 118:280-5. 2006
    ..The aim of this study was to provide data on hospitalization of young children with rotavirus infection in Austria...
  7. ncbi Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Austria
    Vaccine 25:5097-101. 2007
    ....
  8. ncbi Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Centre for Physiology and Pathophysiology, Medical University Vienna, Kinderspitalgasse 15, A 1090 Vienna, Austria
    Vaccine 24:5960-5. 2006
    ....
  9. ncbi Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection
    Maria Paulke-Korinek
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, A 1090 Vienna, Austria
    Vaccine 27:7027-30. 2009
    ..Therefore, recommendations on booster intervals in TBE endemic areas should be adapted by weighting the risk of infection against the risk of short-lived immunity...
  10. ncbi Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees
    Erika Garner-Spitzer
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
    Vaccine 27:197-204. 2009
    ....
  11. ncbi Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria
    Maria Paulke-Korinek
    Institute of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Vienna, Austria
    Vaccine 29:2791-6. 2011
    ..In 2009 the disease burden was highest in children below three months of age stressing the importance of the early start of the immunization course...
  12. ncbi Epidemiology of travel-associated and autochthonous hepatitis A in Austrian children, 1998 to 2005
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Centre for Physiology and Pathophysiology, Medical University Vienna, Vienna, Austria
    J Travel Med 14:248-53. 2007
    ..The aim of the present study was to provide data on disease and hospitalization of children below the age of 15 for imported and autochthonous hepatitis A in Austria...
  13. ncbi Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children
    Maria Paulke-Korinek
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University Vienna, Vienna, Austria
    Pediatr Infect Dis J 29:319-23. 2010
    ..Since July 2007, rotavirus vaccinations have been subsidized in Austria for all children from the seventh week up to the sixth month of life. Vaccination coverage over the whole period was 72% with an increase to 87% in 2008...
  14. ncbi Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines
    Maria Paulke-Korinek
    Department of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, Vienna, Austria
    Vaccine 29:5130-6. 2011
    ..The low levels of antibodies 1-7 years after vaccination against pertussis, rubella and mumps after only one vaccination should be considered when recommending new vaccination schedules...
  15. ncbi Pretravel consultation: rapid dipstick test as a decision guidance for the application of tetanus booster vaccinations
    Maria Paulke-Korinek
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
    J Travel Med 15:437-41. 2008
    ..This immunochromatographic dipstick test yields a positive or negative result...
  16. ncbi Persistence of antibodies after vaccination against tick-borne encephalitis
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Austria
    Int J Med Microbiol 296:202-7. 2006
    ..To summarize, the serological studies included in this analysis generally support a reconsideration of current TBE booster recommendations and a prolongation of booster intervals at least in younger adults...
  17. ncbi Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Kinderspitalgasse 15, A 1090 Vienna, Austria
    Vaccine 24:2781-9. 2006
    ..9%; P = 0.006). Enhanced antibody responses were also found in a population that included low responders...
  18. ncbi Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51
    Elisabeth Schuller
    Intercell AG, Vienna Biocenter 6, Vienna, Austria
    Vaccine 26:6151-6. 2008
    ..0001) but not after the second vaccination with IC51. Thus, pre-existing vaccine-induced TBE immunity enhances the neutralising JEV-specific antibody response after a single IC51 vaccination...
  19. ncbi Advances in vaccination against tick-borne encephalitis
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Austria
    Expert Rev Vaccines 7:589-96. 2008
    ..Systematic TBE case monitoring by raising problem awareness, both inside and outside endemic regions, appears essential to provide evidence for a widely accepted TBE travel-vaccination recommendation in the future...
  20. ncbi Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria
    Pediatr Infect Dis J 26:806-10. 2007
    ..This study was undertaken to analyze epidemiologic trends of laboratory-reported pertussis to evaluate current vaccination strategy in Austria...
  21. ncbi Risk and prevention of tick-borne encephalitis in travelers
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, Medical University of Vienna, Vienna, Austria
    J Travel Med 11:307-12. 2004
  22. ncbi Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population
    Pamela Rendi Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology and Pathophysiology, Medical University Vienna, Vienna, Austria
    Vaccine 25:927-31. 2007
    ..001). The only parameter predicting a titer below 10 mIU/ml 10 years after vaccination was the body mass index (p=0.001). This study confirms that protection following primary hepatitis A vaccination persists for more than 10 years...
  23. ncbi Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, Medical University Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria
    J Antimicrob Chemother 53:826-31. 2004
    ..The surprisingly high level of antimicrobial resistance among invasive isolates considerably amplifies the potential impact of a childhood pneumococcal vaccination programme in Austria...
  24. ncbi Drug prophylaxis for travelers' diarrhea
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, University of Vienna, A-1095 Vienna, Austria
    Clin Infect Dis 34:628-33. 2002
    ....